Related Experiment Video
Updated: Jun 9, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Succession planning in US pharmacy schools
Jenny Van Amburgh1, Christopher K Surratt, James S Green
1Northeastern University, School of Pharmacy, Boston, MA 02115, USA. j.vanamburgh@neu.edu
American Journal of Pharmaceutical Education
|August 28, 2010
Summary
Pharmacy schools need succession planning for leadership transitions. Despite its recognized importance, formal structures are lacking, highlighting a critical gap in academic pharmacy leadership development.
Area of Science:
- Pharmacy Education
- Academic Administration
- Leadership Development
Background:
- Senior administrative faculty in pharmacy schools face imminent retirement.
- The number of pharmacy programs is increasing, exacerbating leadership shortages.
- Succession planning is crucial for organizational continuity and future planning.
Purpose of the Study:
- To explore the perspectives of pharmacy deans on succession planning.
- To assess the current state of succession planning implementation in AACP institutions.
- To identify barriers and needs for succession planning in academic pharmacy.
Main Methods:
- A descriptive study utilizing standardized interview instruments.
- Data collected from 15 deans at AACP institutions.
- Blinded interview data analyzed using analyst triangulation.
Main Results:
- Most deans view succession planning as desirable and necessary.
- No surveyed institution reported having a formal succession planning structure.
- Succession planning is widely adopted in corporate and military sectors but not pharmacy academia.
Conclusions:
- A significant need for succession planning exists within pharmacy schools and colleges.
- Differences in administrative structures may hinder uniform implementation.
- A concerted effort is required to implement succession planning practices in academic pharmacy.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).